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In the present study, we describe the synthesis of alkylseleno carbohydrates with different 
sugar scaffolds and the evaluation of their antioxidant activity profile. A compound possessing a 
C8 alkyl chain presented the best results in the free radical scavenging activity.
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Introduction
The chemistry and biology of simple small molecules 
containing selenium in their structures has received 
increased attention over the past decades. The first of such 
compounds to be developed was ebselen and after the 
discovery of its properties,1,2 a number of different small 
molecules containing selenium have been synthesized.3-8 
The great deal of attention that has been paid to these 
compounds stems from the discovery of a selenium atom at 
the catalytic site of glutathione peroxidase (GPx).9,10 GPx is 
a key enzyme present in mammals with antioxidant activity 
and its mechanism of action involves the reduction of H2O2 
at the expense of the oxidation of glutathione.11,12 A number 
of studies have been reported in the literature describing 
that small organic selenium compounds can effectively 
scavenge and eliminate reactive oxygen species (ROS) 
thus mimicking the activity of GPx enzyme.13-16 ROS are 
commonly generated in normal cellular oxygen metabolism 
playing important biological roles.17 However, an increase 
in the ROS production over cellular endogenous antioxidant 
system capacity of response could result in a condition 
characterized as oxidative stress (OS), which causes damage 
to cells leading to age related degenerative diseases, cancer 
and a wide range of different human diseases.18,19 A simple 
and effective way of preventing these conditions is by 
inhibition of the oxidative damage and, therefore, there 
is a great interest in the search for new organoselenides 
which could represent good pharmacological alternatives 
to counteract oxidative stress. In this context, our groups 
have been interested in the synthesis and biological 
properties of selenium-containing carbohydrates and as 
a result, we have developed a straightforward approach 
for the introduction of an organoselenium moiety at non-
anomeric positions of sugars.20-22 Most of our efforts have 
been focused on the synthesis of arylselenium derivatives 
of carbohydrates and of diselenides, which were used as 
building blocks for the synthesis of more complex non-
glycosidically linked selenium-linked pseudodisaccharides 
and neoglycopeptides.23 In addition, previous studies 
of our group demonstrated that arylseleno-furanosides 
and a carbohydrate-derived diselenide did not inhibited 
δ-aminolevulinate dehydratase (δ-ALA-D), demonstrating 
low toxicity and antioxidant effects.21 More recently, we 
demonstrated that arylseleno-furanoside therapy was 
effective in restoring δ-ALA-D activity from ovary that 
was inhibited by cadmium24 and arylseleno- and aryltelluro-
xylofuranosides attenuate manganese-induced toxicity in 
Caenorhabditis elegans.25
In view of the above, herein we report additional studies 
on this area, more specifically on the synthesis of seleno-
carbohydrates possessing an alkylselenium moiety and the 
evaluation of their in vitro antioxidant profile.
Results and Discussion
Chemistry
The synthesis of the selenocarbohydrates was 
straightforward, and we chose as sugar substrates two 
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furanoside derivatives 2 and 3, readily available from the 
parent carbohydrates D-xylose and D-ribose, respectively, 
and a pyranoside substrate, derived from D-galactose 
(Figure 1).
The tosylates 2-4 reacted with a selenium nucleophile, 
generated by reductive cleavage of the corresponding 
dialkyldiselenide with NaBH4, to yield seleno-carbohydrates 
5-7 (Table 1). The reaction was performed using a 3:1 
mixture of tetrahydrofurane (THF) and ethanol as solvents. 
The tosylate displacement reaction with furanoside 
derivatives 2 and 3 was easier than with the pyranoside 
























Figure 1. Sugar tosylates 2-4.
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reasonable yields of the corresponding products. The 
reason for this behavior is the opposing influence of the 
fixed dipole caused by the presence of the axial C-O bond 
at the C-4, combined with the steric hindrance imposed by 
the acetonide protecting group that hinders the backside 
approach of the selenium nucleophile at C-6.26,27
Deprotection of the acetonide, followed by acetal 
formation at the anomeric position with MeOH, under 
acidic conditions delivered the desired seleno-furanosides 
8a-b, 9a-b, and 10a-b (Scheme 1).
Antioxidant activity
Previous data have demonstrated that the biological 
activity of organoselenium compounds is significantly 
dependent of the substitution pattern of the molecule and 
subtle structural variations can lead to significant differences 
in the biological profile.28-30 With this in mind, we screened 
selected selenocarbohydrates for their in vitro antioxidant 
activity. We first screened the new alkylseleno carbohydrate 
in the 2,2-diphenyl-1-picrylhydrazyl (DPPH), 2,2’-azino-
bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS), 
ferric ion reducing antioxidant power (FRAP) assays. As 
can be seen in Table 2, xylo-pyranoside 8a presented ABTS 
and DPPH radical scavenging at concentration of 50 and 
500 µM, respectively. Compound 8a possessed potent 
inhibitory activity against ABTS radical with IC50 value 
of 210 µM. In addition, compound 8a exhibited ferric-
reducing ability, and the reducing power was improved by 
increasing its concentration. Comparing the values of the 
DPPH, ABTS and FRAP assays, we can suggest that the 
mechanism of antioxidant action of compound 8a is most 
likely based on single electron transfer.
On the other hand, compound 8b, possessing the 
longer C-10 alkyl chain and displaying a ribo-furanoside 


































8a: R = C8H17, 95%







9a: R = C8H17, 80%














10a: R = C8H17, 95%
10b: R = C10H21, 95%
Scheme 1. Synthesis of deprotected seleno-carbohydrates.
Table 2. Antioxidant activity of compound 8a on ABTS, DPPH and FRAP assaysa
µM Scavenging ABTS / % µM Scavenging DPPH / % µM FRAP (absorbance)
10 2.27 ± 1.79 10 0.03 ± 0.05 10 0.19 ± 0.04
50 13.60 ± 1.57c 50 0.26 ± 0.45 50 0.22 ± 0.03
100 25.99 ± 1.61c 100 0.13 ± 0.22 100 0.26 ± 0.02
500 81.69 ± 0.90c 500 5.49 ± 3.40b 500 0.57 ± 0.08c
IC50 210 - - - -
aDenote p < 0.05; bp < 0.01; cp < 0.001 as compared to the respective control sample (one way ANOVA/Newman-Keuls). IC50: concentration (µM) providing 
50% inhibition in the assays. Imax: maximal inhibition (%).
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didn’t show significant results in both DPPH and ABTS 
assays (data not shown).
The galactose-derived compounds 10a-b were also 
evaluated. Galacto-pyranoside 10a presented ABTS 
scavenging at concentration of 500 µM (Table 4) but didn’t 
show significant result in both assays DPPH and FRAP 
(data not shown). On the other hand, results presented in 
Table 5 indicated that galacto-pyranoside derivative 10b 
presented ABTS scavenging at concentrations 50-500 µM 
and exhibited ferric-reducing ability (at 500 µM). However, 
it didn’t exhibit any protection against DPPH radical at any 
concentration tested (data not shown).
Compounds 5b and 9b were also evaluated against 
ABTS, DPPH and FRAP assays but didn’t show any 
significant antioxidant effects. In addition to the ABTS, 
DPPH and FRAP studies, compounds 5b, 8a, 8b, 9b, 
10a and 10b had their superoxide dismutase (SOD)-like, 
nitric oxide31 and hydroxyl radical32 scavenging activities 
evaluated (data not shown) and none of them displayed 
significant activity, therefore ruling out these mechanisms 
as being responsible for their antioxidant profile. 
Inspection of all the results gathered revealed that 
seleno-xylofuranoside 8a, containing an alkyl group with 
eight carbon atoms, showed the highest antioxidant activity 
when compared with the closely related compound 8b 
(with an alkyl group with ten carbon atoms) and seleno-
galactopyranoside 10b, which possesses a C-8 alkyl chain. 
Direct comparison between 8a and the acetonide-protected 
compounds 5a-b revealed that the presence of the acetonide 
moiety has a deleterious effect for the antioxidant activity, 
since 5 did not exhibit antioxidant activity, suggesting that 
the increased water-solubility of 8a when compared to 5a 
might play a role on its antioxidant profile. 
Conclusions
Herein we have reported a straightforward synthesis 
of simple alkylseleno carbohydrates with different sugar 
scaffolds. Screening of selected compounds for antioxidant 
activity revealed that the presence of an alkyl group with 
eight carbon atoms has an important influence in the 
free radical scavenging activity of these compounds and 
therefore they can potentially prevent damage of protein 
and lipids. 
Experimental
General procedure for the synthesis of 5-7
Under an argon atmosphere, sodium borohydride 
(2.5 equiv) was added to a solution of the dialkyldiselenide 
(1.0 mmol) in THF (7.5 mL). Ethanol (2.5 mL) was then 
added dropwise and the clear solution formed was stirred 
at room temperature for 10 min. After this time, a solution 
of the appropriate tosylate (1.5 mmol in 1 mL THF) was 
added dropwise. After stirring under reflux for the time 
indicated in Table 1, the reaction mixture was quenched with 
aqueous saturated NH4Cl (10 mL) and extracted with CH2Cl2 
(3 × 25 mL). The combined organic layers were dried with 
MgSO4, filtered and concentrated. The crude product was 
purified by flash chromatography, first eluting with hexanes 
and then with a mixture of hexanes/ethyl acetate.
Analytical data for compound 5a: yield 65%; white 
solid; purified using hexane:EtOAc 80:20; [α]D20 = -54 
(c 1.0, AcOEt); m.p. 62 °C; IR (film) νmax/cm-1 3398, 2922, 
1372, 1217, 1089, 1014, 817; 1H NMR (300 MHz, CDCl3) 
δ 5.93 (d, 1H, J 3.7 Hz, CH), 4.53 (d, 1H, J 3,7 Hz, CH), 
4.34 (ddd, 1H, J 9.0, 5.3, 2.5 Hz, CH), 4.27 (dd, 1H, J 5.3, 
2.5 Hz, CH), 2.82 (dq, 2H, J 12.0, 7.3 Hz, CH2), 2.69-2.60 
(m, 2H, CH2), 1.72-1.62 (m, 2H, CH2), 1.50 (s, 3H, CH3), 
Table 5. Antioxidant activity of compound 10b on ABTS and FRAP assaysa
µM Scavenging ABTS / % µM FRAP (absorbance)
10 3.04 ± 4.10 10 0.20 ± 0.04
50 12.47 ± 3.74 50 0.20 ± 0.03
100 24.90 ± 5.81c 100 0.23 ± 0.06
500 21.01 ± 7.87b 500 0.54 ± 0.07c
aDenote p < 0.05; bp < 0.01; cp < 0.001 as compared to the respective 
control sample (one way ANOVA/Newman-Keuls).
Table 4. Antioxidant activity of compound 10a on ABTS assaya
µM Scavenging ABTS / %
10 3.47 ± 0.47
50 4.24 ± 3.93
100 7.64 ± 4.90
500 31.77 ± 19.26b
aDenote p < 0.05; bp < 0.01 as compared to the respective control sample 
(one way ANOVA/Newman-Keuls).
Table 3. Antioxidant activity of compound 8b on FRAP assaya
µM FRAP (absorbance)
10 0.19 ± 0.06
50 0.19 ± 0.04
100 0.20 ± 0.03
500 0.65 ± 0.07b
aDenote p < 0.05; bp < 0.01 as compared to the respective control sample 
(one way ANOVA/Newman-Keuls).
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1.43-1.27 (m, 10H, 5 × CH2), 1.31 (s, 3H, CH3), 0.88 (t, 
3H, J 6.7 Hz, CH3); 
13C NMR (75 MHz, CDCl3) δ 111.5, 
104.7, 85.0, 80.1, 75.0, 31.7, 30.5, 29.7, 29.0, 28.9, 26.6, 
26.0, 24.9, 22.5, 19.9, 13.9; HRMS-ESI m/z calcd. for 
C16H30O4Se + Na
+: 389.1202; found: 389.1206.
General procedure for the synthesis of 8 and 10
In a round bottomed flask, the appropriate 
selenocarbohydrate (0.5 mmol) was stirred in an aqueous 
solution of trifluoracetic acid (50% v/v, 10 mL) for 1 h at 
room temperature. After this time, the reaction mixture 
was concentrated in vacuum, co-evaporated with toluene 
(3 × 10 mL) and the residue dissolved in MeOH (10 mL), 
in the presence of a catalytic amount of sulfuric acid, and 
stirred for additional 24 h, at room temperature. Following 
this time, the mixture was neutralized by the addition of 
solid sodium bicarbonate. The mixture was filtered and the 
solvents evaporated to afford the product.
Analytical data for compound 8a: yield 95%; yellow 
oil; mixture of anomers (1.0:0.66); IR (film) νmax/cm-1 3421, 
2925, 1456, 1208, 1112, 1024; 1H NMR (300 MHz, CDCl3) 
δ 4.99 (d, 0.46H, J 4.5 Hz, CHβ), 4.85 (s, 0.7H, CHα), 4.51 
(ddd, 0.7H, J 7.9, 6.9, 4.1 Hz, CH), 4.36 (ddd, 0.46H, J 7.4, 
6.5, 5.1 Hz, CH), 4.24 (dd, 0.7H, J 4.5, 3.7 Hz, CH), 4.20 
(s, 0.7H, CH), 4.13 (dd, 0.46H, J 4.1, 3.5 Hz, CH), 4.07 (d, 
0.46H, J 4.6 Hz, CH), 3.49 (s, 1.38H, CH3α) 3.38 (s, 2.1H, 
CH3β), 2.82 (m, 4H, 2 × CH2), 2.64 (m, 4H, 2 × CH2), 1.67 
(m, 4H, 2 × CH2), 1.30 (m, 20H, 2 × 5 × CH2), 0.88 (t, 6H, 
J 6.8 Hz, 2 × CH3); 
13C NMR (75 MHz, CDCl3) δ 108.5, 
101.7, 83.5, 79.6, 78.6, 78.5, 77.0, 76.2, 55.8, 55.1, 31.7, 
30.6, 30.5, 29.87, 29.82, 29.12, 29.10, 29.06, 29.03, 24.91, 
24.87, 22.65, 22.56, 21.9, 14.0.
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